Skip to main content

Table 1 Patients’ characteristics

From: Early and mid-term outcomes after aortic valve intervention in patients with previous stentless or stented bioprostheses

Variable

N—Stented

Stat—Stented

N—Stentless

Stat—Stentless

P value

Age at time of surgery (yrs)

100

66 (54–77)

12

74 (67–79)

0.135

Sex of patient

100

 

12

 

0.181

Female

 

28 (28%)

 

1 (8%)

 

Male

 

72 (72%)

 

11 (92%)

 

Diabetes Mellitus (insulin or non-insulin dependent)

100

 

12

 

1.00

 Yes

 

18 (18%)

 

2 (17%)

 

 Medically treated hypertension

100

 

12

 

0.35

 Yes

 

57 (57%)

 

9 (75%)

 

 Diet or medically treated hyperlipidemia

100

 

12

 

0.76

 Yes

 

58 (58%)

 

6 (50%)

 

Chronic obstructive pulmonary disease—severe

100

 

11

 

0.41

 Yes

 

4 (4%)

 

1 (9%)

 Previous stroke or T.I.A

100

 

12

 

0.69

 Yes

 

19 (19%)

 

1 (8%)

 

 Evidence of any atherosclerotic lesion outside of the heart and proximal aorta

100

 

12

 

0.69

 Yes

 

8 (8%)

 

2 (17%)

 

 Pre-op dialysis

100

 

12

 

0.29

 Yes

 

1 (1%)

 

1 (8%)

 

 Family history of heart disease including stroke, PVD, MI, angina, or heart surgery

100

 

11

 

0.20

 Yes

 

47 (47%)

 

4 (36%)

0.58

Smoking history

100

 

12

 

1.00

 Never smoked

 

45 (45%)

 

6 (50%)

 

 Still smoking

 

7 (7%)

 

0 (0%)

 

Stopped smoking

 

48 (48%)

 

6 (50%)

1.00

 Pre-op atrial fibrillation/flutter

100

 

12

 

1.00

 Yes

 

15 (15%)

 

2 (17%)

 

Pre-op complete heart block

100

 

12

 

1.00

 Yes

 

9 (9%)

 

0 (0%)

 

 Congestive Heart Failure

100

 

12

 

0.59

 Yes

 

66 (66%)

 

8 (67%)

 

 Shock

100

 

12

 

1.00

 Yes

 

1 (1%)

 

1 (8%)

 

 Syncopal episodes

100

 

12

 

0.20

 Yes

 

2 (2%)

 

0 (0%)

 

 Aortic valve disease

100

 

11

 

1.00

 Mixed

 

26 (26%)

 

2 (18%)

 

 None

 

7 (7%)

 

1 (9%)

 

 Regurgitation (greater than mild: > 2 +)

 

44 (44%)

 

4 (36%)

0.66

 Stenosis

 

23 (23%)

 

4 (36%)

 

 Mitral valve disease

100

 

12

  

 Missing

 

1 (1%)

 

0 (0%)

 

 Mixed

 

2 (2%)

 

0 (0%)

 

 None

 

85 (85%)

 

12 (100%)

0.54

 Regurgitation (greater than mild: > 2+)

 

12 (12%)

 

0 (0%)

 

 Tricuspid valve disease

100

 

12

  

 None

 

94 (94%)

 

12 (100%)

 

 Regurgitation (greater than mild: > 2+)

 

5 (5%)

 

0 (0%)

 

 Stenosis

 

1 (1%)

 

0 (0%)

1.00